NMTR
Geode Capital Management’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-108,821
| Closed | -$73.1K | – | 4871 |
|
|
2023
Q2 | $73.1K | Sell |
108,821
-3
| -0% | -$2 | ﹤0.01% | 4427 |
|
|
2023
Q1 | $151K | Sell |
108,824
-1
| -0% | -$1 | ﹤0.01% | 4171 |
|
|
2022
Q4 | $137K | Sell |
108,825
-2,203,871
| -95% | -$2.77M | ﹤0.01% | 4277 |
|
|
2022
Q3 | $497K | Hold |
2,312,696
| – | – | ﹤0.01% | 3731 |
|
|
2022
Q2 | $603K | Sell |
2,312,696
-1,493,098
| -39% | -$389K | ﹤0.01% | 3658 |
|
|
2022
Q1 | $2.28M | Sell |
3,805,794
-58,968
| -2% | -$35.3K | ﹤0.01% | 3197 |
|
|
2021
Q4 | $3.78M | Buy |
3,864,762
+240,704
| +7% | +$236K | ﹤0.01% | 3045 |
|
|
2021
Q3 | $4.71M | Buy |
3,624,058
+250,549
| +7% | +$326K | ﹤0.01% | 2939 |
|
|
2021
Q2 | $3.71M | Buy |
3,373,509
+2,064,365
| +158% | +$2.27M | ﹤0.01% | 3071 |
|
|
2021
Q1 | $1.53M | Buy |
1,309,144
+504,669
| +63% | +$590K | ﹤0.01% | 3384 |
|
|
2020
Q4 | $691K | Buy |
804,475
+431,772
| +116% | +$371K | ﹤0.01% | 3487 |
|
|
2020
Q3 | $303K | Buy |
372,703
+236,557
| +174% | +$192K | ﹤0.01% | 3592 |
|
|
2020
Q2 | $77K | Buy |
136,146
+22,178
| +19% | +$12.5K | ﹤0.01% | 3916 |
|
|
2020
Q1 | $57K | Hold |
113,968
| – | – | ﹤0.01% | 3899 |
|
|
2019
Q4 | $63K | Hold |
113,968
| – | – | ﹤0.01% | 4055 |
|
|
2019
Q3 | $121K | Sell |
113,968
-2,662
| -2% | -$2.83K | ﹤0.01% | 3906 |
|
|
2019
Q2 | $135K | Sell |
116,630
-60,628
| -34% | -$70.2K | ﹤0.01% | 3885 |
|
|
2019
Q1 | $342K | Buy |
177,258
+8,836
| +5% | +$17K | ﹤0.01% | 3573 |
|
|
2018
Q4 | $389K | Buy |
168,422
+33,606
| +25% | +$77.6K | ﹤0.01% | 3462 |
|
|
2018
Q3 | $920K | Buy |
134,816
+87,059
| +182% | +$594K | ﹤0.01% | 3255 |
|
|
2018
Q2 | $1.13M | Buy |
+47,757
| New | +$1.13M | ﹤0.01% | 3131 |
|